Binding assay and assay reagent
First Claim
Patent Images
1. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein said iridum complex is Ir(bipy)2 (4'"'"'- 1,10-phenanthroline)!-phenoxy-acetic acid)3+.
3 Assignments
0 Petitions
Accused Products
Abstract
A time-resolving luminescence binding assay involves a metal-labelled binding partner comprising a luminescent transition metal complex covalently attached to a binding partner such as an antigen or antibody. Ruthenim, iridium, osmium, and chromium luminescent complexes are described.
-
Citations
5 Claims
-
1. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein said iridum complex is Ir(bipy)2 (4'"'"'- 1,10-phenanthroline)!-phenoxy-acetic acid)3+.
-
2. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein said iridium complex is Ir(bipy)2 (4"-carboxybenzyl-4'"'"'- 4(1,10-phenanthroline)!-phenyl ether3+.
-
3. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein iridium complex is Ir(bipy)2 (4,7-diphenyl-1,10-phenanthroline)3+.
-
4. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein said iridium complex is Ir(bipy)2 (2,2'"'"'-biquinoline)3+.
-
5. A metal-labeled binding partner comprising a binding partner covalently bonded to a luminescent iridium complex, wherein said iridium complex is Ir(phen)2 (4'"'"'- 4-(1,10,10-phenanthroline)!-phenoxy-acetic acid)3+.
Specification